These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 32028670)

  • 41. Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.
    Komar CM
    Reprod Biol Endocrinol; 2005 Aug; 3():41. PubMed ID: 16131403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.
    Arck P; Toth B; Pestka A; Jeschke U
    Biol Reprod; 2010 Aug; 83(2):168-76. PubMed ID: 20427759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
    J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
    Ibabe A; Herrero A; Cajaraville MP
    Toxicol In Vitro; 2005 Sep; 19(6):725-35. PubMed ID: 15964169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peroxisome proliferator-activated receptors and angiogenesis.
    Biscetti F; Straface G; Pitocco D; Zaccardi F; Ghirlanda G; Flex A
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):751-9. PubMed ID: 19628379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.
    Liao HH; Jia XH; Liu HJ; Yang Z; Tang QZ
    Curr Pharm Des; 2017; 23(11):1677-1686. PubMed ID: 27779079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Peroxisome proliferator-activated receptors (PPAR). Antiproliferative properties].
    Hojka A; Rapak A
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():404-13. PubMed ID: 21734325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Peroxisome proliferator-activated receptor(PPAR)--structure, function, tissue distribution, gene expression].
    Takeyama K; Kodera Y; Suzawa M; Kato S
    Nihon Rinsho; 2000 Feb; 58(2):357-63. PubMed ID: 10707558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
    Kliewer SA; Lehmann JM; Milburn MV; Willson TM
    Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PPARs: molecular targets in the pharmacogenomics era.
    Seda O; Sedová L
    Prague Med Rep; 2004; 105(3):223-36. PubMed ID: 15782550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
    Berger J; Wagner JA
    Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S; Dahal Lamichane B; Kwon SM
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [PPARs, metabolic syndrome and cardiac diseases].
    Carvajal K; Hernández-Esquivel Mde L; Moreno-Sánchez R
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-66-76. PubMed ID: 18938701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.